Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
ProPhotonix Honored by Vision Systems Design 2018 Innovators Awards Program
-
Tiberius Acquisition Corporation Common Stock And Warrants To Commence Trading Separately On April 10, 2018
-
Freddie Mac Prices $1 Billion Multifamily K-Deal, K-731
-
Cantor Fitzgerald Remains Bullish on Shire (SHPG)
-
UPDATE: Cantor Fitzgerald Downgrades NewLink Genetics (NLNK) to Neutral
-
ProPhotonix Limited - STKR - ProPhotonix Announces Holding(s) in Company
-
NewLink Genetics (NLNK) Defended at Cantor
-
Prophotonix Posts Notice Of Annual General Meeting
-
Paratek Pharmaceuticals (PRTK) PT Maintained at $50 at Cantor Fitzgerald on Omadacycline NDA Acceptance; 'Time to Make PRTK a Priority'
-
Strongbridge Biopharma (SBBP) 'Firing on All Cylinders' - Cantor Fitzgerald
-
ProPhotonix Limited Announces PDMR Shareholding
-
Cantor Highlights Square (SQ) From A Fundamental And Technical Basis
-
Rigel Pharmaceuticals (RIGL) PT Lowered to $6 at Cantor Fitzgerald Following Phase 2 Data
-
Celgene (CELG): COO Departure An Incremental Positive - Cantor Fitzgerald
-
Alkermes (ALKS) PT Lowered to $45 at Cantor Fitzgerald
-
Ur-Energy Announces Appointment of New Board Member: Rob Chang
-
Humana (HUM): Thoughts On Potential Walmart Acquisition - Cantor Fitzgerald
-
Acorda Therapeutics, Inc. (ACOR) PT Raised to $17 at Cantor Fitzgerald
-
Agile Therapeutics (AGRX) PT Lowered to $4 at Cantor Fitzgerald
-
Aldeyra Therapeutics (ALDX) PT Raised to $23 at Cantor Fitzgerald
-
Let The Shire (SHPG) Bidding War Begin - Cantor
-
Prometic Reports its Q4-2017 and YE-2017 Financial Results and Provides Update on Activities
-
Cantor Fitzgerald Starts Tahoe Resources (TAHO) at Buy
-
Tiberius Acquisition Corporation Announces Closing of Underwriters' Full Over-Allotment Option in Connection with its Initial Public Offering
-
Aptose Biosciences Establishes New At-the-Market Facility
-
FactSet Research Systems (FDS) PT Raised to $203 at Cantor Fitzgerald
-
IHS Markit (INFO) PT Raised to $51 at Cantor Fitzgerald
-
Allscripts (MDRX) Weakness Overdone - Cantor Fitzgerald
-
Celsion Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results
-
M III Acquisition Corp. Completes Merger With IEA Services LLC
-
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
-
Freddie Mac Prices $667 Million Multifamily K-Deal
-
Auryn Resources Announces Closing of US$9.8 Million Financing
-
Cantor Fitzgerald Remains Overweight on Radius Health (RDUS) Following Negative EMA Vote
-
Prophotonix Posts 2017 Annual Report and Accounts
-
Arena Pharma (ARNA) Prices 8.5M Share Common Offering at $41.50/Sh
-
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Abeona Therapeutics (ABEO) PT Raised to $36 at Cantor Fitzgerald
-
Xencor (XNCR) Prices 7.3M Share Common Offering at $31/Sh
-
Tiberius Acquisition Corporation Announces Closing of $150,000,000 Initial Public Offering
-
Xencor Announces Pricing of Public Offering of Common Stock
-
Arena Pharma (ARNA) to Offer 7.5M Shares of Common Stock
-
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Arena Pharma (ARNA) PT Raised to $64 at Cantor Fitzgerald
-
HealthEquity, Inc (HQY) PT Raised to $65 at Cantor Fitzgerald Following 4Q
-
IPA Chapters Bring Education and Networking Directly to PDI Industry
-
Heron Therapeutics (HRTX) PT Raised to $40 at Cantor Fitzgerald
-
Hamilton Zanze and Cantor Fitzgerald Joint Venture Acquires Las Vegas Multifamily Property
-
ProPhotonix Announces Holding(s) in Company
-
Aurinia Pharmaceuticals (AUPH) PT Raised to $16 at Cantor Fitzgerald

